FDA Orange Book · active-ingredient family
Vismodegib
Vismodegib is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ERIVEDGE · NDA 203388
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ERIVEDGERLD | GENENTECH | NDA 203388 | — | Jan 30, 2012 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7888364 | Nov 11, 2028 | in 2 yr 5 mo | SubstanceProduct |
| 9278961 | Dec 15, 2028 | in 2 yr 6 mo | U-1825 |
Vismodegib — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
